Literature DB >> 23369087

Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.

Mehdi Yousefi1, Fathollah Tahmasebi, Vahid Younesi, Alireza Razavi, Jalal Khoshnoodi, Ali Ahmad Bayat, Ebrahim Abbasi, Hodjatallah Rabbani, Mahmood Jeddi-Tehrani, Fazel Shokri.   

Abstract

Clostridium tetani causes a life-threatening infectious disease by production of tetanus neurotoxin (TeNT), a 150 kDa molecule composed of light (LC) and heavy chain (HC) polypeptides. The TeNT HC contains an N-terminal domain critical for LC translocation and a C-terminal toxin receptor-binding domain known as fragment C. Despite extensive investigations on epitope specificity of anti-TeNT antibodies, the immunodominant neutralizing epitopes of the toxin are poorly defined. This study describes the generation and characterization of four monoclonal antibodies (MAb) specific for TeNT. The characteristics of each MAb were explored in terms of isotype, specificity, affinity, and immuno-globulin heavy chain variable region (IGHV) gene usage using ELISA, Western blotting, and sequencing techniques. The toxin neutralizing activity of the MAbs was also investigated using the in vitro GT1b neutralizing assay. The data demonstrated that all MAbs bind to tetanus toxin and toxoid. Sub-fragments binding analysis showed that two MAbs react with fragment C, one with both fragment C and LC, and one with LC. Only the two fragment C-specific MAbs were able to neutralize the toxin. Sequencing of the expressed VH and VL genes revealed rearrangements of various VH and VL gene segments in all hybridoma clones. Clonality of the hybridomas was also confirmed by a competition assay that showed recognition of distinct epitopes by these MAbs. The results suggest the importance of TeNT fragment C in terms of immunogenicity and toxin neutralization activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23369087     DOI: 10.3109/1547691X.2013.763872

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  4 in total

1.  Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.

Authors:  Mehdi Yousefi; Roya Khosravi-Eghbal; Ahmad Reza Mahmoudi; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Hum Vaccin Immunother       Date:  2013-10-14       Impact factor: 3.452

2.  Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.

Authors:  Somayeh Ghotloo; Mohammad Mehdi Amiri; Jalal Khoshnoodi; Ebrahim Abbasi; Mahmood Jeddi-Tehrani; Forough Golsaz-Shirazi; Fazel Shokri
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

3.  Production and characterization of recombinant light chain and carboxyterminal heavy chain fragments of tetanus toxin.

Authors:  Mehdi Yousefi; Roya Khosravi-Eghbal; Azam Hemmati; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2013-10

4.  The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.

Authors:  Rui Yu; Chong Ji; Junjie Xu; Denghai Wang; Ting Fang; Yue Jing; Clifton Kwang-Fu Shen; Wei Chen
Journal:  Biomed Res Int       Date:  2018-12-31       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.